<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials
Image Overlay - Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

May 25, 2020

Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

Astrazeneca’s vaccine candidate has advanced to clinical trials with the prospect that it will be available by September. Yourway supports clinical trials to get them advanced to the clinic.

 Back to Index
Media

Upcoming Events

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?